INTRODUCTION AND OBJECTIVES: In the second part of an analysis of a 10-year period of treating oral cancer patients, the focus was the efficiency of treatment, recurrence rates and survival. PATIENTS AND METHODS: From 1485 patients with oral and maxillofacial malignant tumours, 1072 cases could be evaluated. The following data were analyzed statistically: patients' charts and medical records including the follow-up reports. RESULTS: From all patients studied, 811 underwent surgical treatment alone, the mean recurrence rate was 23%. The recurrence rate after surgery plus radiotherapy was 38%; after surgical treatment alone it was 23%; the survival rate at 3 and 5 years post-therapeutically was 49% and 31%, respectively. CONCLUSIONS: The first choice therapy for carcinomas is surgical. The recurrence rate increased with lymph node involvement and tumour size.
RCT Entities:
INTRODUCTION AND OBJECTIVES: In the second part of an analysis of a 10-year period of treating oral cancerpatients, the focus was the efficiency of treatment, recurrence rates and survival. PATIENTS AND METHODS: From 1485 patients with oral and maxillofacial malignant tumours, 1072 cases could be evaluated. The following data were analyzed statistically: patients' charts and medical records including the follow-up reports. RESULTS: From all patients studied, 811 underwent surgical treatment alone, the mean recurrence rate was 23%. The recurrence rate after surgery plus radiotherapy was 38%; after surgical treatment alone it was 23%; the survival rate at 3 and 5 years post-therapeutically was 49% and 31%, respectively. CONCLUSIONS: The first choice therapy for carcinomas is surgical. The recurrence rate increased with lymph node involvement and tumour size.
Authors: Eva Krauss; Stephan Rauthe; Stefan Gattenlöhner; Tobias Reuther; Michael Kochel; Ulrike Kriegebaum; Alexander C Kübler; Urs D A Müller-Richter Journal: Clin Oral Investig Date: 2010-02-20 Impact factor: 3.573